反応式
[Cl:1][C:2]1[CH:3]=[CH:4][C:5]2[N:11]3[C:12]([CH3:21])=[N:13][C:14]([N:15]4[CH2:20][CH2:19][O:18][CH2:17][CH2:16]4)=[C:10]3[CH2:9][N+:8]([O-])=[C:7]([C:23]3[CH:28]=[CH:27][CH:26]=[CH:25][C:24]=3[F:29])[C:6]=2[CH:30]=1.Cl[Si](Cl)(Cl)[Si](Cl)(Cl)Cl.C(Cl)Cl>C1(C)C=CC=CC=1>[Cl:1][C:2]1[CH:3]=[CH:4][C:5]2[N:11]3[C:12]([CH3:21])=[N:13][C:14]([N:15]4[CH2:20][CH2:19][O:18][CH2:17][CH2:16]4)=[C:10]3[CH2:9][N:8]=[C:7]([C:23]3[CH:28]=[CH:27][CH:26]=[CH:25][C:24]=3[F:29])[C:6]=2[CH:30]=1参加物
5
実験手順
A mixture of 0.2 g of 8-chloro-6-(2-fluorophenyl)-1-methyl-3-morpholino-4H-imidazo[1,5-a][1,4]-benzodiazepine 5-oxide, 0.2 ml of hexachlorodisilane and 10 ml of methylene chloride was allowed to sit for two days. It was then diluted with toluene and washed with 1 N sodium hydroxide solution. The organic phase was dried and evaporated. Crystallization of the residue from ether/hexane gave end product with mp 172°-174° C.
後処理
- washwashed with 1 N sodium hydroxide solution
- customThe organic phase was dried
- customevaporated
- customCrystallization of the residue from ether/hexane
- customgave end product with mp 172°-174° C.
出典と根拠
- ORDレコード
- ord-5cf16a1add3946ab9d84a4e6b2ca78d0
- 出典データセット
- uspto-grants-1981_01
- 特許番号
- US04244867
関連ノート
読み込み中…